Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.88 | C | |
| $10.90 | C | |
| $14.65 | C |